Should Patients with Hepatic Fibrosis Undergo LVAD Implantation: A Comparative Analysis

Authors

Linnea Xuereb, Henry Ford HealthFollow
Pauline H. Go, Henry Ford Health
Babbaljeet Kaur, Henry Ford Health
Silvy Akrawe, Henry Ford HealthFollow
Jamil Borgi, Henry Ford Health
Gaetano Paone, Henry Ford HealthFollow
Jeffrey A. Morgan, Henry Ford Health

Recommended Citation

Xuereb L, Go PH, Kaur B, Akrawe S, Borgi J, Paone G, Morgan JA. Should Patients with Hepatic Fibrosis Undergo LVAD Implantation: A Comparative Analysis. ASAIO J. 2016 Jul-Aug;62(4):498-500.

Document Type

Article

Publication Date

7-1-2016

Publication Title

ASAIO journal (American Society for Artificial Internal Organs : 1992)

Abstract

The purpose of our study was to evaluate outcomes in patients with hepatic fibrosis at the time of LVAD implantation. There were five (2.1%) patients with preoperative hepatic fibrosis with a mean age of 51.2 ± 16.8 years. Survival at 180 days was significantly reduced in patients with hepatic fibrosis, 40.0% vs. 88.0%; p = 0.001. Hepatic fibrosis was a significant independent predictor of mortality in multivariate analysis (hazard ratio [HR] 2.27, p = 0.036).

Medical Subject Headings

Adult; Aged; Heart-Assist Devices; Humans; Liver Cirrhosis; Male; Middle Aged; Multivariate Analysis

PubMed ID

27014788

Volume

62

Issue

4

First Page

498

Last Page

500